Moreover, cancer cells are able to elevate the level of immune checkpoint molecules such as Cytotoxic T-lymphocyte associated protein 4 (CTLA-4) and programmed death-ligand 1 (PD-1), which help them suppress the immune response [89]. Here, CTLA4 is linked to cancer.